| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9f360e61c05947a100c17ca995ab88de |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate |
2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94400189a324562bebb27cdb1f484510 |
| publicationDate |
2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-032457-B1 |
| titleOfInvention |
COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF ACUTE AND CHRONIC HEPATITIS AND CHOLESTASIS |
| abstract |
The proposed composition for the treatment and / or prevention of diseases of the liver and / or biliary tract, including ursodeoxycholic acid (UDCA) and glycyrrhizic acid (HA) and / or its pharmacologically acceptable salts or metabolites, in which the weight ratio of UDCA to HA is (1.0 -114.0) :( 1.0-10.0). The composition has advantages over monocomponent compositions, and preparations based on this composition may have a corresponding perspective in medical practice. |
| priorityDate |
2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |